Utah Medical Products (NASDAQ: UTMD)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-21 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.964 | ||||||
REV | 12.323M |
You can purchase shares of Utah Medical Products (NASDAQ: UTMD) through any online brokerage.
Other companies in Utah Medical Products’s space includes: RxSight (NASDAQ:RXST), Meridian Bioscience (NASDAQ:VIVO), BioLife Solns (NASDAQ:BLFS), Embecta (NASDAQ:EMBC) and ICU Medical (NASDAQ:ICUI).
There is no analysis for Utah Medical Products
The stock price for Utah Medical Products (NASDAQ: UTMD) is $88.4302 last updated Today at June 28, 2022, 5:16 PM UTC.
A quarterly cash dividend of $0.29 per share of Class A Common Stock. The quarterly cash dividend was payable on July 6, 2022 to stockholders of record on June 16, 2022.
Utah Medical Products’s Q2 earnings are confirmed for Thursday, July 21, 2022.
There is no upcoming split for Utah Medical Products.
Utah Medical Products is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.